Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.19 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.19 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.19 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AM.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AM.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.15 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.15 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.15 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.113NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.113NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.113NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.5.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.5.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.88NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AP.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
AP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.98.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.98.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.98.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.13.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.13.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.34.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.34.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.34.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.124.1.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.124.1.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.124.1.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.203NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.203NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.203NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.8.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used